89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.

Ulaner, Gary A

89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. [electronic resource] - Clinical nuclear medicine Dec 2017 - 912-917 p. digital

Publication Type: Clinical Trial; Journal Article

1536-0229

10.1097/RLU.0000000000001820 doi


Adult
Antibodies, Monoclonal, Humanized
Breast Neoplasms--diagnostic imaging
Female
Humans
Middle Aged
Neoplasm Metastasis
Positron Emission Tomography Computed Tomography
Prospective Studies
Receptor, ErbB-2--metabolism